Amicus Therapeutics Inc. buy Morgan Stanley
Start price
19.12.23
/
50%
€12.00
Target price
19.12.24
€18.24
Performance (%)
-22.50%
End price
20.12.24
€9.30
Summary
This prediction ended on 20.12.24 with a price of €9.30. The prediction for Amicus Therapeutics Inc. disappointed with a performance of -22.50%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -1.681% | -1.681% | 27.174% |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $15.00.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.45
11.10.24
11.10.24
€16.44
11.10.25
11.10.25
-24.34%
12.10.25
12.10.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.60
10.05.24
10.05.24
€17.64
10.05.25
10.05.25
-37.79%
11.05.25
11.05.25